Skip to main content

International Journal of Clinical Oncology OnlineFirst articles

Open Access 26.04.2024 | Original Article

Availability of genome-matched therapy based on clinical practice

Next-generation sequencing (NGS) is a DNA-sequencing technology that performs sequencing from millions of small fragments of DNA in parallel [ 1 ]. NGS-based comprehensive genomic profiling (CGP) enables the detection of large numbers of …

verfasst von:
Naomi Hayashi, Seiichi Mori, Akihiro Ohmoto, Ippei Fukada, Masumi Yamazaki, Mari Hosonaga, Xiaofei Wang, Arisa Ueki, Kazuma Kiyotani, Akiko Tonooka, Kengo Takeuchi, Shunji Takahashi

24.04.2024 | Original Article

Significance of radiation therapy in the myxoid round-cell liposarcoma treatment regimen

A myxoid liposarcoma (MLS) is a liposarcoma subtype comprising uniform, round-to-ovoid cells with variable numbers of small lipoblasts set in a myxoid stroma with a branching capillary vasculature [ 1 ]. MLS presents distinct clinical features …

verfasst von:
Akiyoshi Shimatani, Hirohisa Katagiri, Hideki Murata, Junji Wasa, Michihito Miyagi, Yosuke Honda, Mitsuru Takahashi, Hiroyuki Harada, Hirofumi Asakura, Tsuyoshi Onoe

23.04.2024 | Special Article

Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022

Granulocyte colony-stimulating factor (G-CSF) is used in the primary prophylaxis of febrile neutropenia (FN) to improve the safety of chemotherapy, and it is recommended in some guidelines [ 1 – 4 ]. In Japan, two types of G-CSF are available. One …

verfasst von:
Tetsuhiro Yoshinami, Kazuki Nozawa, Takamichi Yokoe, Yukinori Ozaki, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, Dai Maruyama, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Mamoru Ito, Eishi Baba, Nobuaki Ochi, Toshio Kubo, Keita Uchino, Takahiro Kimura, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano

23.04.2024 | Original Article

SlicerPIT: software development and implementation for planning and image-guided therapy in photoimmunotherapy

Photoimmunotherapy (PIT) is a treatment modality in which molecular-targeted drugs activated by infrared light are selectively bound to the cell membranes of tumor cells, and the lesions are then irradiated with near-infrared light to induce …

verfasst von:
Takayoshi Suzuki, Satoshi Kano, Masanobu Suzuki, Seijiro Hamada, Hiroshi Idogawa, Nayuta Tsushima, Yuichi Ashikaga, Yuki Wakabayashi, Takeshi Soyama, Yasuhiro Hida, Akihiro Homma

23.04.2024 | Original Article

Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis

Retroperitoneal sarcomas (RPS) are a heterogeneous group of soft tissue sarcomas (STSs) of retroperitoneal mesenchymal origin, accounting for approximately 15–20% of STSs [ 1 ]. Retroperitoneal liposarcoma (RLPS) is the main histological type of …

verfasst von:
Guoqiang Xue, Zhen Wang, Bonan Liu, Chengpeng Li, Ang lv, Xiuyun Tian, Jianhui Wu, Hui Qiu, Chunyi Hao

22.04.2024 | JSCO Board of Directors Series

Biomarker-oriented chemo-immunotherapy for advanced gastric cancer

The biomarker-oriented chemo-immunotherapy is useful and promising in the development of new anticancer agents, since the responders can be enriched by selecting patients with biomarkers. Compared to colorectal and lung cancers, the development of …

verfasst von:
Koji Kono, Shotaro Nakajima, Kosaku Mimura

20.04.2024 | Original Article

Clinicopathological characteristics of Lynch-like syndrome

Colorectal cancer (CRC) is one of the most common solid tumors, and details associated with its carcinogenesis have been intensively studied over the past two decades. Most instances of CRC are microsatellite-stable, owing to the inactivation of …

verfasst von:
Sakiko Nakamori, Misato Takao, Akinari Takao, Soichiro Natsume, Takeru Iijima, Ekumi Kojika, Daisuke Nakano, Kazushige Kawai, Takuhiko Inokuchi, Ai Fujimoto, Makiko Urushibara, Shin-ichiro Horiguchi, Hideyuki Ishida, Tatsuro Yamaguchi

17.04.2024 | Original Article

A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer

Recently, high-precision external beam radiotherapy has been introduced widely in Japan. Intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) are effective techniques for external beam radiotherapy for localized prostate …

verfasst von:
Katsumasa Nakamura, Keiji Nihei, Yoshihiro Saito, Naoto Shikama, Shin-ei Noda, Ryusuke Hara, Toshiyuki Imagumbai, Takashi Mizowaki, Takeshi Akiba, Etsuo Kunieda, Masanori Someya, Saiji Ohga, Jiro Kawamori, Takuyo Kozuka, Yosuke Ota, Koji Inaba, Takeshi Kodaira, Yoshiyuki Itoh, Kouta Funakoshi, Yoshikazu Kagami

17.04.2024 | Invited Review Article

New therapeutic target molecules for gastric and gastroesophageal junction cancer

Molecularly targeted therapy for receptor tyrosine kinases (RTKs) has faced limitations in gastric and gastroesophageal junction (G/GEJ) cancer except for HER2-targeted agents, possibly due to inappropriate assay selection that has hindered …

verfasst von:
Hisato Kawakami

Open Access 16.04.2024 | JSCO Board of Directors Series

Early experience and future prospects regarding use of newly developed surgical robot system, hinotori, in the field of urologic cancer surgery

In the field of urology, robotic surgery has gained rapid and wide acceptance as a standard surgical approach in the majority of major surgeries over the last decade. To date, the da Vinci surgical system has been the dominant platform in robotic …

verfasst von:
Hideaki Miyake, Masato Fujisawa

16.04.2024 | PMDA Regulatory Update

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval of nivolumab for unresectable advanced or recurrent epithelial skin malignancies in Japan

After completion of the review by Pharmaceuticals and Medical Devices Agency (PMDA), nivolumab was approved in Japan in February 9, 2024 for unresectable advanced or recurrent epithelial skin malignancies [ 1 ].

verfasst von:
Noriomi Matsumura, Masaki Mandai

15.04.2024 | Invited Review Article

Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers

Breast cancer is the most prevalent cancer among women, and its diagnosis requires the accurate identification and classification of histological features for effective patient management. Artificial intelligence, particularly through deep …

verfasst von:
Ayaka Katayama, Yuki Aoki, Yukako Watanabe, Jun Horiguchi, Emad A. Rakha, Tetsunari Oyama

Open Access 14.04.2024 | Original Article

Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome

Recently, utilization of immune checkpoint inhibitors in the treatment of DNA mismatch repair deficient (dMMR) solid tumors has gained significant attention [ 1 , 2 ]. Currently, two major methods are used to identify dMMR in the tumors, molecular …

verfasst von:
Tetsuya Ito, Tatsuro Yamaguchi, Kensuke Kumamoto, Okihide Suzuki, Noriyasu Chika, Satoru Kawakami, Tomonori Nagai, Tsukasa Igawa, Kenji Fujiyoshi, Yoshito Akagi, Tomio Arai, Kiwamu Akagi, Hidetaka Eguchi, Yasushi Okazaki, Hideyuki Ishida

Open Access 13.04.2024 | Special Article

English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology

The Japan Society of Clinical Oncology Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) have been published in accordance with the Minds Manual for Guideline Development 2014 and 2017. A specialized team independent of …

verfasst von:
Seiichi Hirota, Ukihide Tateishi, Yuji Nakamoto, Hidetaka Yamamoto, Shinji Sakurai, Hirotoshi Kikuchi, Tatsuo Kanda, Yukinori Kurokawa, Haruhiko Cho, Toshirou Nishida, Akira Sawaki, Masato Ozaka, Yoshito Komatsu, Yoichi Naito, Yoshitaka Honma, Fumiaki Takahashi, Hironobu Hashimoto, Midori Udo, Minako Araki, Sumito Nishidate, Members of the Systematic Review Team of the Present Guidelines

11.04.2024 | Original Article

Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinoma

Adenocarcinoma is the most common type of lung cancer worldwide [ 1 ]. Among the histological subtypes of invasive non-mucinous adenocarcinoma, it often presents as mixed histology, which includes a combination of lepidic, acinar, papillary …

verfasst von:
Toru Kimura, Takashi Akazawa, Yu Mizote, Harumi Nakamura, Miki Sakaue, Tomohiro Maniwa, Yasushi Shintani, Keiichiro Honma, Hideaki Tahara, Jiro Okami

10.04.2024 | Original Article

Preoperative predictive factors for positive peritoneal cytology results in patients with pancreatic ductal adenocarcinomas: a retrospective study

Intraoperative peritoneal washing cytology (CY) is widely used for diagnosing and staging ovarian and gastric cancers [ 1 , 2 ]. In gastric cancer, a positive peritoneal cytology (PPC) result is diagnosed as distant metastasis (M1). PPC is also …

verfasst von:
Gaku Shimane, Yutaka Nakano, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Yasushi Hasegawa, Shigeyoshi Soga, Shigeo Okuda, Ryota Ishii, Yuko Kitagawa

09.04.2024 | Original Article

Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy

Chemoradiotherapy (CRT), followed by total mesorectal excision (TME), is the standard treatment for patients with locally advanced rectal cancer [ 1 ]. In recent years, close observation without surgery in cases that demonstrated a good response to …

verfasst von:
Kazushige Kawai, Kosuke Ozaki, Daisuke Nakano, Akira Dejima, Ichiro Ise, Sakiko Nakamori, Hiroki Kato, Soichiro Natsume, Misato Takao, Tatsuro Yamaguchi, Soichiro Ishihara

Open Access 08.04.2024 | Original Article

Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab

Human epidermal growth factor 2 (HER2) is one of the famous oncogenes in breast and gastric cancer [ 1 ]. HER2 overexpression or its gene amplification have been reported up to 20% in gastric cancer [ 2 – 4 ], suggesting that it is a critical …

verfasst von:
Takeru Wakatsuki, Naoki Ishizuka, Shuichi Hironaka, Keiko Minashi, Shigenori Kadowaki, Masahiro Goto, Hirokazu Shoji, Hidekazu Hirano, Izuma Nakayama, Hiroki Osumi, Mariko Ogura, Keisho Chin, Kensei Yamaguchi, Daisuke Takahari

08.04.2024 | Original Article

Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancer

A low skeletal muscle mass (LSMM), measured using imaging modalities, has been reported to be associated with poor oncological outcomes in various cancers (including prostate cancer [PCa]) [ 1 ]. LSMM is defined as the skeletal muscle mass with two …

verfasst von:
Shunsuke Owa, Takeshi Sasaki, Ryota Ikadai, Yusaku Tabata, Yushiro Takeuchi, Taketomo Nishikawa, Momoko Kato, Shinichiro Higashi, Yusuke Sugino, Satoru Masui, Kouhei Nishikawa, Takahiro Inoue

Open Access 07.04.2024 | Original Article

Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database

verfasst von:
Chuyue Zhang, Bin Li, Yan Yang